Literature DB >> 12364511

Pharmacology of nicotinic receptors in preBötzinger complex that mediate modulation of respiratory pattern.

Xuesi M Shao1, Jack L Feldman.   

Abstract

Nicotine regulates respiratory pattern by modulating excitatory neurotransmission affecting inspiratory neurons within the preBötzinger Complex (preBötC). The nicotinic acetylcholine receptor (nAChR) subtypes mediating these effects are unknown. Using a medullary slice preparation from neonatal rat, we recorded spontaneous respiratory-related rhythm from the hypoglossal nerve (XIIn) and patch-clamped inspiratory neurons in the preBötC simultaneously. The alpha7 nAChR antagonists alpha-bungarotoxin or methyllycaconitine (MLA) had little effect on the actions of low concentrations of nicotine (0.5 microM), which included an increase in respiratory frequency; a decrease in amplitude of XIIn inspiratory bursts; a tonic inward current associated with an increase in membrane noise; an increase in the frequency and amplitude of spontaneous excitatory postsynaptic currents (sEPSCs), and; a decrease in the amplitude of inspiratory drive current in voltage-clamped preBötC inspiratory neurons. These nicotinic actions were completely reversed by dihydro-beta-erythroidine (DH-beta-E) or hexamethonium and reduced by D-tubocurarine. Comparable concentrations of RJR-2403 (0.5-1 microM), an agonist selective for alpha4beta2 nAChRs, increased respiratory frequency to 186% and decreased the amplitude of XIIn inspiratory bursts to 83% of baseline. In voltage-clamped preBötC inspiratory (including pacemaker) neurons, RJR-2403 induced a tonic inward current of -15.2 pA associated with an increase in membrane noise, increased the frequency to 157% and amplitude to 106% of spontaneous EPSCs, and decreased the amplitude of inspiratory drive current to 80% of baseline. MLA had little effect on RJR-2403 actions, while DH-beta-E completely reversed them. These results suggest that the predominant subtype of nAChRs in preBötC in neonatal rats that mediates the modulation of respiratory pattern by low concentrations of nicotine is an alpha4beta2 combination and not an alpha7 subunit homomer. We do not exclude the possibility that co-assembly of alpha4beta2 with other subunits or other nAChR subtypes are also expressed in preBötC neurons. The parallel changes in the cellular and systems level responses induced by different nicotinic agonists and antagonists support the idea that modulation of excitatory neurotransmission affecting preBötC inspiratory neurons is a mechanism underlying the cholinergic regulation of respiratory pattern (). This study provides a useful model system for evaluating potential therapeutic cholinergic agents for their respiratory effects and side effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364511      PMCID: PMC4337837          DOI: 10.1152/jn.2002.88.4.1851

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  50 in total

1.  Models of respiratory rhythm generation in the pre-Bötzinger complex. II. Populations Of coupled pacemaker neurons.

Authors:  R J Butera; J Rinzel; J C Smith
Journal:  J Neurophysiol       Date:  1999-07       Impact factor: 2.714

2.  RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization.

Authors:  M Bencherif; M E Lovette; K W Fowler; S Arrington; L Reeves; W S Caldwell; P M Lippiello
Journal:  J Pharmacol Exp Ther       Date:  1996-12       Impact factor: 4.030

Review 3.  Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness.

Authors:  G G Nomikos; B Schilström; B E Hildebrand; G Panagis; J Grenhoff; T H Svensson
Journal:  Behav Brain Res       Date:  2000-08       Impact factor: 3.332

4.  Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors.

Authors:  C W Luetje; J Patrick
Journal:  J Neurosci       Date:  1991-03       Impact factor: 6.167

5.  Identification of four classes of brain nicotinic receptors using beta2 mutant mice.

Authors:  M Zoli; C Léna; M R Picciotto; J P Changeux
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

6.  Effects of acetylcholine on respiratory neurones in the nucleus ambiguus-retroambigualis complex of the cat.

Authors:  D Jordan; K M Spyer
Journal:  J Physiol       Date:  1981-11       Impact factor: 5.182

7.  Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat.

Authors:  E Wada; K Wada; J Boulter; E Deneris; S Heinemann; J Patrick; L W Swanson
Journal:  J Comp Neurol       Date:  1989-06-08       Impact factor: 3.215

8.  Central respiratory effects versus neuromuscular actions of nerve agents.

Authors:  D L Rickett; J F Glenn; E T Beers
Journal:  Neurotoxicology       Date:  1986       Impact factor: 4.294

9.  Effects of caffeine on ventilation during acute and chronic nicotine administration in rhesus monkeys.

Authors:  L L Howell
Journal:  J Pharmacol Exp Ther       Date:  1995-06       Impact factor: 4.030

10.  Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei.

Authors:  R Klink; A de Kerchove d'Exaerde ; M Zoli; J P Changeux
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

View more
  18 in total

1.  Increased nicotinic receptor desensitization in hypoglossal motor neurons following chronic developmental nicotine exposure.

Authors:  Jason Q Pilarski; Hilary E Wakefield; Andrew J Fuglevand; Richard B Levine; Ralph F Fregosi
Journal:  J Neurophysiol       Date:  2011-10-19       Impact factor: 2.714

2.  The role of spiking and bursting pacemakers in the neuronal control of breathing.

Authors:  Jan-Marino Ramirez; Henner Koch; Alfredo J Garcia; Atsushi Doi; Sebastien Zanella
Journal:  J Biol Phys       Date:  2011-03-22       Impact factor: 1.365

3.  Perinatal exposure to nicotine causes deficits associated with a loss of nicotinic receptor function.

Authors:  Gary Cohen; Jean-Christophe Roux; Régis Grailhe; Girvan Malcolm; Jean-Pierre Changeux; Hugo Lagercrantz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

4.  Cholinergic neurotransmission in the preBötzinger Complex modulates excitability of inspiratory neurons and regulates respiratory rhythm.

Authors:  X M Shao; J L Feldman
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

5.  Identification of a cholinergic modulatory and rhythmogenic mechanism within the lamprey respiratory network.

Authors:  Donatella Mutolo; Elenia Cinelli; Fulvia Bongianni; Tito Pantaleo
Journal:  J Neurosci       Date:  2011-09-14       Impact factor: 6.167

6.  Acute toxicity of organophosphorus compounds in guinea pigs is sex- and age-dependent and cannot be solely accounted for by acetylcholinesterase inhibition.

Authors:  William P Fawcett; Yasco Aracava; Michael Adler; Edna F R Pereira; Edson X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  2008-11-04       Impact factor: 4.030

7.  The development of nicotinic receptors in the human medulla oblongata: inter-relationship with the serotonergic system.

Authors:  Jhodie R Duncan; David S Paterson; Hannah C Kinney
Journal:  Auton Neurosci       Date:  2008-11-05       Impact factor: 3.145

Review 8.  Central cholinergic regulation of respiration: nicotinic receptors.

Authors:  Xuesi M Shao; Jack L Feldman
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

Review 9.  Prenatal nicotine exposure and development of nicotinic and fast amino acid-mediated neurotransmission in the control of breathing.

Authors:  Ralph F Fregosi; Jason Q Pilarski
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

10.  Prenatal nicotine exposure alters medullary nicotinic and AMPA-mediated control of respiratory frequency in vitro.

Authors:  Jason Q Pilarski; Ralph F Fregosi
Journal:  Respir Physiol Neurobiol       Date:  2009-08-03       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.